Hatsue Fujino Selected Research

Hatsue Fujino Research Topics

Disease

46	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 12/2013
17	Neoplasms (Cancer) 11/2023 - 12/2014
10	Fibrosis (Cirrhosis) 03/2024 - 06/2015
10	Liver Cirrhosis (Hepatic Cirrhosis) 03/2024 - 06/2015
10	Chronic Hepatitis C 01/2021 - 10/2014
9	Infections 01/2023 - 05/2016
7	Neoplasm Metastasis (Metastasis) 11/2023 - 12/2014
6	Liver Diseases (Liver Disease) 01/2023 - 03/2017
5	Hepatic Encephalopathy 09/2023 - 03/2018
4	Hepatitis B 01/2023 - 03/2017
3	Non-alcoholic Fatty Liver Disease 01/2023 - 03/2014
3	Chronic Hepatitis B 01/2021 - 01/2018
3	Thrombosis (Thrombus) 10/2020 - 06/2015
2	Portal Hypertension 03/2024 - 11/2020
2	Proteinuria 11/2023 - 08/2023
2	Acute-On-Chronic Liver Failure 10/2023 - 10/2023
2	Acute Liver Failure (Fulminant Hepatic Failure) 09/2023 - 08/2014
2	Inflammation (Inflammations) 01/2023 - 07/2019
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 03/2014
2	Insulin Resistance 03/2022 - 12/2014
2	Hepatitis 01/2021 - 12/2018
2	Fever (Fevers) 01/2021 - 03/2011
2	Necrosis 01/2021 - 01/2018
2	Microsatellite Instability 10/2020 - 07/2020
2	Edema (Dropsy) 02/2020 - 08/2016
2	Sarcopenia 02/2020 - 03/2019
2	Chronic Hepatitis (Chronic Active Hepatitis) 01/2020 - 12/2018
2	Disease Progression 01/2020 - 07/2019
2	Brain Diseases (Brain Disorder) 08/2019 - 07/2014
1	Virus Diseases (Viral Diseases) 03/2024
1	Overweight 02/2024
1	Anorexia 11/2023
1	Fatigue 11/2023
1	Hypertension (High Blood Pressure) 11/2023
1	Pain (Aches) 11/2023
1	Weight Loss (Weight Reduction) 01/2023

Drug/Important Bio-Agent (IBA)

16	lenvatinibIBA 11/2023 - 08/2019
12	atezolizumabIBA 03/2024 - 08/2021
12	Bevacizumab (Avastin)FDA Link 03/2024 - 08/2021
9	Antiviral Agents (Antivirals)IBA 01/2023 - 08/2016
7	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 12/2013
7	InterferonsIBA 11/2020 - 12/2014
7	Ribavirin (Virazole)FDA LinkGeneric 01/2020 - 10/2014
6	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2018
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2024 - 05/2016
4	CytokinesIBA 09/2023 - 01/2018
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023 - 12/2014
4	daclatasvirIBA 01/2020 - 08/2016
4	asunaprevirIBA 01/2020 - 08/2016
3	Prothrombin (Factor II)IBA 09/2023 - 12/2014
3	Proteins (Proteins, Gene)FDA Link 08/2023 - 01/2020
3	Alanine Transaminase (SGPT)IBA 01/2023 - 01/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 03/2014
3	Hemoglobins (Hemoglobin)IBA 01/2023 - 11/2016
3	EnzymesIBA 02/2021 - 10/2019
3	AntigensIBA 01/2021 - 03/2017
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2017
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 03/2017
3	telaprevirIBA 12/2014 - 10/2014
2	nasIBA 03/2024 - 08/2020
2	Alkaline PhosphataseIBA 03/2024 - 10/2019
2	Interleukin-6 (Interleukin 6)IBA 10/2023 - 10/2023
2	AlbuminsIBA 08/2023 - 10/2019
2	CreatinineIBA 08/2023 - 08/2016
2	BilirubinIBA 08/2023 - 10/2019
2	NucleotidesIBA 01/2023 - 01/2018
2	Therapeutic UsesIBA 01/2023 - 07/2021
2	Blood Glucose (Blood Sugar)IBA 01/2023 - 03/2022
2	Immune Checkpoint InhibitorsIBA 02/2021 - 10/2020
2	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 03/2017
2	regorafenibIBA 01/2021 - 01/2021
2	Fetal Proteins (Fetoprotein)IBA 11/2020 - 01/2018
2	SofosbuvirIBA 11/2020 - 12/2018
2	pembrolizumabIBA 10/2020 - 07/2020
2	pibrentasvirIBA 04/2020 - 03/2019
2	glecaprevirIBA 04/2020 - 03/2019
2	ChemokinesIBA 07/2019 - 01/2018
2	entecavir FDA Link 12/2018 - 01/2018
2	HMGB1 Protein (HMG1)IBA 01/2018 - 01/2018
1	Collagen Type I (Type I Collagen)IBA 11/2023
1	Denosumab FDA Link 11/2023
1	collagen type I trimeric cross-linked peptideIBA 11/2023
1	Zoledronic Acid (Zometa)FDA Link 11/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2023
1	Interleukin-8 (Interleukin 8)IBA 09/2023
1	Interleukin-4 (Interleukin 4)IBA 09/2023
1	Serum AlbuminIBA 08/2023
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2023
1	Uric Acid (Urate)IBA 01/2023
1	LipidsIBA 01/2023
1	SodiumIBA 01/2023

Therapy/Procedure

34	Therapeutics 03/2024 - 03/2011
7	Drug Therapy (Chemotherapy) 10/2020 - 12/2013
3	Liver Transplantation 09/2023 - 03/2017
3	Surgical Portasystemic Shunt (Portosystemic Shunt) 08/2019 - 07/2014
2	Aftercare (After-Treatment) 10/2023 - 01/2023
2	Radiotherapy 01/2023 - 10/2020
2	Glycemic Control 03/2022 - 03/2014
2	Hepatectomy 01/2022 - 08/2019
1	Activities of Daily Living (ADL) 11/2023